Mostrar registro simples

dc.contributor.authorVisioli, Fernandapt_BR
dc.contributor.authorWang, Yugangpt_BR
dc.contributor.authorAlam, Goleeta N.pt_BR
dc.contributor.authorNing, Yupt_BR
dc.contributor.authorRados, Pantelis Varvakipt_BR
dc.contributor.authorNor, Jacques Eduardopt_BR
dc.contributor.authorPolverini, Peter J.pt_BR
dc.date.accessioned2014-10-11T02:11:48Zpt_BR
dc.date.issued2014pt_BR
dc.identifier.issn1932-6203pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/104482pt_BR
dc.description.abstractObjectives: This study was designed to investigate the activation of the unfolded protein response (UPR) in tumor associated endothelial cells (TECs) and its association with chemoresistance during acidic pH stress. Materials and Methods: Endothelial cells from human oral squamous cell carcinomas (OSCC) were excised by laser capture microdissection (LCM) followed by analysis of UPR markers (Grp78, ATF4 and CHOP) using quantitative PCR. Grp78 expression was also determined by immunostaining. Acidic stress was induced in primary human dermal microvascular endothelial cells (HDMECs) by treatment with conditioned medium (CM) from tumor cells grown under hypoxic conditions or by adjusting medium pH to 6.4 or 7.0 using lactic acid or hydrochloric acid (HCl). HDMEC resistance to the antiangiogenic drug Sunitinib was assessed with SRB assay. Results: UPR markers, Grp78, ATF4 and CHOP were significantly upregulated in TECs from OSCC compared to HDMECs. HDMECs cultured in acidic CM (pH 6.0–6.4) showed increased expression of the UPR markers. However, severe acidosis led to marked cell death in HDMECs. Alternatively, HDMECs were able to adapt when exposed to chronic acidosis at pH 7.0 for 7 days, with concomittant increase in Grp78 expression. Chronic acidosis also confers drug resistance to HDMECs against Sunitinib. Knockdown of Grp78 using shRNA resensitizes HDMECs to drug treatment. Conclusions: UPR induction in ECs under acidic pH conditions is related to chemoresistance and may contribute to therapeutic failures in response to chemotherapy. Targeting Grp78, the key component of the UPR pathway, may provide a promising approach to overcome ECs resistance in cancer therapy.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofPLOS ONE. São Francisco. Vol. 9, no. 6 (June 2014), e101053, 9 p.pt_BR
dc.rightsOpen Accessen
dc.subjectCélulas endoteliaispt_BR
dc.subjectNeoplasias bucaispt_BR
dc.subjectResposta a proteínas não dobradaspt_BR
dc.titleGlucose-regulated protein 78 (Grp78) confers chemoresistance to tumor endothelial cells under acidic stresspt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb000922206pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples